Skip to main content
Clinical Trials/IRCT20221122056579N1
IRCT20221122056579N1
Recruiting
Phase 3

Comparison of Local Subcutaneous Infiltration with Ropivacaine Alone or Two Different Doses of Dexmedetomidine plus Ropivacaine for Postoperative Pain After Cesarean Section Under Spinal Anesthesia.

Esfahan University of Medical Sciences0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Esfahan University of Medical Sciences
Enrollment
90
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients who are candidates for cesarean surgery (for the first time)
  • Performing cesarean surgery under spinal anesthesia
  • ASA I\&II (American society of anesthesiologists)

Exclusion Criteria

  • Patients with a History of Drug Allergy (Dexmedetomidine And Ropivacaine)
  • Patients with a History of Tobacco and Opioid Addiction
  • Patients with Psychological Problems
  • Obese Patients Weighing More Than 100 kg
  • Patients with Inability to Express Pain Score
  • Suffering from Intracranial Hypertension
  • Twin Pregnancy and Above
  • Previous Abdominal and Pelvic Surgeries
  • Uncontrollable Underlying Disease (ASA3 and higher)

Outcomes

Primary Outcomes

Not specified

Similar Trials